(Updates movement, adds ASX-listed shares)
    ** New Zealand's Fisher and Paykel Healthcare Corp  FPH.NZ 
rises as much as 8.9% to NZ$36.210, marks biggest intraday pct
gain since March 24
    ** Medical device maker says operating revenue for the nine
months ended Dec. 31 up 73% on a constant currency basis
 urn:newsml:reuters.com:*:nNZW7HjZmv
    ** Says experienced strong hospital hardware sales due to
high hospitalisation rates during the COVID-19 pandemic
    ** Expects FY revenue and NPAT to be higher than previous
forecast due to sustained demand for hardware; co's prev. NPAT
forecast range NZ$400 mln to NZ$415 mln ($288.56 mln - $299.38
mln)
    ** Says cannot provide formal guidance for the full year due
to COVID-19 uncertainties
    ** Stock touches highest level since Nov. 9, top pct gainer
in the NZ 50 index  .NZ50  and powers the benchmark to a 1.7%
rise
    ** Shares up ~1% this year, as of last close 
    ** Co's ASX-listed shares  FPH.AX  climb 8% to be
second-biggest pct gainers on the Aussie benchmark  .AXJO 

($1 = 1.3862 New Zealand dollars)

 (Reporting by Anushka Trivedi & Savyata Mishra in Bengaluru)
 ((Savyata.mishra@thomsonreuters.com))